These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28496190)

  • 1. Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial.
    Pilcher J; Patel M; Pritchard A; Thayabaran D; Ebmeier S; Shaw D; Black P; Braithwaite I; Weatherall M; Beasley R
    NPJ Prim Care Respir Med; 2017 May; 27(1):33. PubMed ID: 28496190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.
    Pilcher J; Patel M; Smith A; Davies C; Pritchard A; Travers J; Black P; Weatherall M; Beasley R; Harwood M;
    Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma.
    Patel M; Pilcher J; Reddel HK; Qi V; Mackey B; Tranquilino T; Shaw D; Black P; Weatherall M; Beasley R;
    J Allergy Clin Immunol Pract; 2014; 2(6):751-8. PubMed ID: 25439367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.
    McCormack PL; Lyseng-Williamson KA
    Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis.
    Patel M; Pilcher J; Hancox RJ; Sheahan D; Pritchard A; Braithwaite I; Shaw D; Black P; Weatherall M; Beasley R;
    NPJ Prim Care Respir Med; 2015 Jan; 25():14099. PubMed ID: 25569185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma.
    Lipworth B; Kuo CR; Stewart K; Chan R
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):889-893. PubMed ID: 38346474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines.
    Lin J; Zhou X; Wang C; Liu C; Cai S; Huang M
    Expert Rev Respir Med; 2018 Mar; 12(3):191-202. PubMed ID: 29400090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of smoking status on the efficacy of the SMART regimen in high risk asthma.
    Pilcher J; Patel M; Reddel HK; Pritchard A; Black P; Shaw D; Holt S; Weatherall M; Beasley R
    Respirology; 2016 Jul; 21(5):858-66. PubMed ID: 26897389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?
    Patel M; Pilcher J; Beasley R
    Expert Rev Respir Med; 2013 Oct; 7(5):451-4. PubMed ID: 24138688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metrics of salbutamol use as predictors of future adverse outcomes in asthma.
    Patel M; Pilcher J; Reddel HK; Pritchard A; Corin A; Helm C; Tofield C; Shaw D; Black P; Weatherall M; Beasley R;
    Clin Exp Allergy; 2013 Oct; 43(10):1144-51. PubMed ID: 24074332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.
    Jenkins CR; Eriksson G; Bateman ED; Reddel HK; Sears MR; Lindberg M; O'Byrne PM
    BMC Pulm Med; 2017 Apr; 17(1):65. PubMed ID: 28427362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: effects on eosinophilic airway inflammation.
    Takeyama K; Kondo M; Tagaya E; Kirishi S; Ishii M; Ochiai K; Isono K; Tamaoki J
    Allergy Asthma Proc; 2014; 35(2):141-7. PubMed ID: 24717791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapy.
    Ställberg B; Naya I; Ekelund J; Eckerwall G
    Int J Clin Pharmacol Ther; 2015 Jun; 53(6):447-55. PubMed ID: 25907171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.
    van Dijkman SC; Yorgancıoğlu A; Pavord I; Brusselle G; Pitrez PM; Oosterholt S; Fumali S; Majumdar A; Della Pasqua O
    Adv Ther; 2024 Mar; 41(3):1201-1225. PubMed ID: 38296921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma?
    Beasley R; Weatherall M; Shirtcliffe P; Hancox R; Reddel HK
    J Allergy Clin Immunol; 2014 Jan; 133(1):39-41. PubMed ID: 24369798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.